Inflammation in atrial fibrillation

Journal of the American College of Cardiology

Volumn 60, Issue 22, 2012, Pages 2263-2270

  Guo, Yutao ^a,b   Lip, Gregory Y H ^a   Apostolakis, Stavros ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

atrial fibrillation; inflammation; prothrombotic state

Indexed keywords

ATORVASTATIN; C REACTIVE PROTEIN; CD40 LIGAND; FIBRINOGEN; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; P SELECTIN GLYCOPROTEIN LIGAND 1; PADGEM PROTEIN; PLACEBO; THROMBOPLASTIN; TUMOR NECROSIS FACTOR ALPHA; VON WILLEBRAND FACTOR;

ARTICLE; CARDIOVERSION; CATHETER ABLATION; CEREBROVASCULAR ACCIDENT; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; HEART ATRIUM APPENDAGE; HEART ATRIUM FIBRILLATION; HUMAN; INFLAMMATION; LEUKOCYTE ACTIVATION; NONHUMAN; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOEMBOLISM;

EID: 84870226617     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.04.063     Document Type: Review

References (46)

1. T. Watson, E. Shantsila, G.Y. Lip Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited Lancet 373 2009 155 166
2. P. Prage, D. Hisham, T. Peter, L. Nasser Update on the association of inflammation and atrial fibrillation J Cardiovasc Electrophysiol 21 2010 1064 1070
3. K. Friedrichs, A. Klinke, S. Baldus Inflammatory pathways underlying atrial fibrillation Trend Molec Med 17 2011 556 563
4. S. Devaraj, U. Singh, I. Jialal The evolving role of C-reactive protein in atherothrombosis Clin Chem 55 2009 229 238
5. I. Rizos, A.G. Rigopoulos, A.S. Kalogeropoulos Hypertension and paroxysmal atrial fibrillation: a novel predictive role of high sensitivity C-reactive protein in cardioversion and long-term recurrence J Hum Hypertens 24 2010 447 457
6. S.C. Marott, B.G. Nordestgaard, J. Zacho Does elevated C-reactive protein increase atrial fibrillation risk? A Mendelian randomization of 47,000 individuals from the general population J Am Coll Cardiol 56 2010 789 795
7. S. Ederhy, E. Di Angelantonio, G. Dufaitre C-reactive protein and transesophageal echocardiographic markers of thromboembolism in patients with atrial fibrillation Int J Cardiol 159 2012 40 46
8. Y.C. Qu, Y.M. Du, S.L. Wu, Q.X. Chen, H.L. Wu, S.F. Zhou Activated nuclear factor-kappaβ and increased tumor necrosis factor-alpha in atrial tissue of atrial fibrillation Scand Cardiovasc J 43 2009 292 297
9. H. Deng, Y.M. Xue, X.Z. Zhan, H.T. Liao, H.M. Guo, S.L. Wu Role of tumor necrosis factor-alpha in the pathogenesis of atrial fibrillation Chin Med J 124 2011 1976 1982
10. J. Li, J. Solus, Q. Chen Role of inflammation and oxidative stress in atrial fibrillation Heart Rhythm 7 2010 438 444
11. A. Pinto, A. Tuttolomondo, A. Casuccio Immuno-inflammatory predictors of stroke at follow-up in patients with chronic non-valvular atrial fibrillation (NVAF) Clin Sci (Lond) 116 2009 781 789
12. K. Olejniczak, A. Kasprzak Biological properties of interleukin 2 and its role in pathogenesis of selected diseases - a review Med Sci Monit 14 2008 RA179 RA189
13. Hak, J. Myśliwska, J. Wieckiewicz, K. Szyndler, J. Siebert, J. Rogowski Interleukin-2 as a predictor of early postoperative atrial fibrillation after cardiopulmonary bypass graft (CABG) J Interferon Cytokine Res 29 2009 327 332
14. A. Kourliouros, I. Savelieva, A. Kiotsekoglou, M. Jahangiri, J. Camm Current concepts in the pathogenesis of atrial fibrillation Am Heart J 157 2009 243 252
15. G.M. Marcus, M.A. Whooley, D.V. Glidden, L. Pawlikowska, J.G. Zaroff, J.E. Olgin Interleukin-6 and atrial fibrillation in patients with coronary artery disease: data from the Heart and Soul Study Am Heart J 155 2008 303 309
16. D.I. Leftheriotis, K.T. Fountoulaki, P.G. Flevari The predictive value of inflammatory and oxidative markers following the successful cardioversion of persistent lone atrial fibrillation Int J Cardiol 135 2009 361 369
17. F. Burzotta, A.D. Blann, B. Balakrishnan Characterisation and validity of inflammatory biomarkers in the prediction of post-operative atrial fibrillation in coronary artery disease patients Thromb Haemost 104 2010 122 127
18. D.S. Conway, S.K. Therkelsen, H. Bruunsgaard, K.S. Krabbe, B.K. Pedersen, J.H. Svendsen Prognostic impact of hs-CRP and IL-6 in patients with persistent atrial fibrillation treated with electrical cardioversion Scand J Clin Lab Invest 69 2009 425 432
19. K.M. Henningsen, B. Nilsson, H. Bruunsgaard, X. Chen, B.K. Pedersen, J.H. Svendsen Prognostic impact of hs-CRP and IL-6 in patients undergoing radiofrequency catheter ablation for atrial fibrillation Scand Cardiovasc J 43 2009 285 291
20. V. Melenovsky, G.Y. Lip Interleukin-8 and atrial fibrillation Europace 10 2008 784 785
21. L. Liuba, H. Ahlomroth, L. Jonasson Source of inflammatory markers in patients with atrial fibrillation Europace 10 2008 848 853
22. L. De Gennaro, N.D. Brunetti, D. Montrone, F. De Rosa, A. Cuculo, M. Di Biase Inflammatory activation and carbohydrate antigen-125 levels in subjects with atrial fibrillation Eur J Clin Invest 42 2012 371 375
23. R.B. Schnabel, M.G. Larson, J.F. Yamamoto Relation of multiple inflammatory biomarkers to incident atrial fibrillation Am J Cardiol 104 2009 92 96
24. P.L. Pellegrino, N.D. Brunetti, L.D. Gennaro, L. Ziccardi, M. Grimaldi, M.D. Biase Inflammatory activation in an unselected population of subjects with atrial fibrillation: links with structural heart disease, atrial remodeling and recent onset Intern Emerg Med 2011 Mar 30 [E-pub ahead of print]
25. G.M. Marcus, L. Smith, K. Ordovas Intracardiac and extracardiac markers of inflammation during atrial fibrillation Heart Rhythm 7 2010 149 154
26. D. Conen, P.M. Ridker, B.M. Everett A multimarker approach to assess the influence of inflammation on the incidence of atrial fibrillation in women Eur Heart J 31 2010 1730 1736
27. G.M. Marcus, L.M. Smith, D.V. Glidden Markers of inflammation before and after curative ablation of atrial flutter Heart Rhythm 5 2008 215 221
28. E.M. Kallergis, E.G. Manios, E.M. Kanoupakis The role of the post-cardioversion time course of hs-CRP levels in clarifying the relationship between inflammation and persistence of atrial fibrillation Heart 94 2008 200 204
29. J.G. Akar, W. Jeske, D.J. Wilber Acute onset human atrial fibrillation is associated with local cardiac platelet activation and endothelial dysfunction J Am Coll Cardiol 51 2008 1790 1793
30. J.C. Kaski, A.L. Arrebola-Moreno Inflammation and thrombosis in atrial fibrillation Rev Esp Cardiol 64 2011 551 553
31. D. Tousoulis, K. Zisimos, C. Antoniades Oxidative stress and inflammatory process in patients with atrial fibrillation: the role of left atrium distension Int J Cardiol 136 2009 258 262
32. A. Raviele, F. Ronco Endothelial dysfunction and atrial fibrillation: what is the relationship? J Cardiovasc Electrophysiol 22 2011 383 384
33. D. Yacoub, A. Hachem, J.F. Theoret, M.A. Gillis, W. Mourad, Y. Merhi Enhanced levels of soluble cd40 ligand exacerbate platelet aggregation and thrombus formation through a cd40-dependent tumor necrosis factor receptor-associated factor-2/rac1/p38 mitogen-activated protein kinase signaling pathway Arterioscler Thromb Vasc Biol 30 2010 2424 2433
34. E. Shantsila, G.Y. Lip The role of monocytes in thrombotic disorders Thromb Haemost 102 2009 916 924
35. A. Choudhury, I. Chung, N. Panja, J. Patel, G.Y. Lip Soluble cd40 ligand, platelet surface cd40 ligand, and total platelet cd40 ligand in atrial fibrillation: relationship to soluble p-selectin, stroke risk factors, and risk factor intervention Chest 134 2008 574 581
36. B. Pamukcu, G.Y. Lip, V. Snezhitskiy, E. Shantsila The CD40-CD40L system in cardiovascular disease Ann Med 43 2011 331 340
37. C. Cunnington, D. Tousoulis, C. Stefanadis Preoperative scd40l levels predict risk of atrial fibrillation after off-pump coronary artery bypass graft surgery Circulation 120 Suppl 2009 170 176
38. H. Duygu, V. Barisik, H. Kurt, U. Turk, E. Ercan, S. Kose Prognostic value of plasma soluble cd40 ligand in patients with chronic non-valvular atrial fibrillation Europace 10 2008 210 214
39. M. Hayashi, K. Takeshita, Y. Inden Platelet activation and induction of tissue factor in acute and chronic atrial fibrillation: involvement of mononuclear cell-platelet interaction Thrombosis Research 128 2011 e113 e118
40. H. Almroth, N. Hoglund, K. Boman Atorvastatin and persistent atrial fibrillation after cardioversion: a randomized placebo controlled multicentre study Eur Heart J 30 2009 827 833
41. K. Ohara, H. Inoue, T. Nozawa Accumulation of risk factors enhances the prothrombotic state in atrial fibrillation Int J Cardiol 126 2008 316 321
42. V. Roldán, F. Marín, B. Muiña Plasma von Willebrand factor levels are an independent risk factor for adverse events including mortality and major bleeding in anticoagulated atrial fibrillation patients J Am Coll Cardiol 57 2011 2496 2504
43. F. Marín, J. Corral, V. Roldán Factor XIII Val34Leu polymorphism modulates the prothrombotic and inflammatory state associated with atrial fibrillation J Mol Cell Cardiol 37 2004 699 704
44. M. Barber, R.C. Tait, J. Scott, A. Rumley, G.D. Lowe, D.J. Stott Dementia in subjects with atrial fibrillation: hemostatic function and the role of anticoagulation J Thromb Haemost 2 2004 1873 1878
45. J. Heeringa, D.S. Conway, D.A. van der Kuip A longitudinal population-based study of prothrombotic factors in elderly subjects with atrial fibrillation: the Rotterdam Study 1990-1999 J Thromb Haemost 4 2006 1944 1949
46. A. Choudhury, I. Chung, A.D. Blann, G.Y. Lip Platelet surface CD62P and CD63, mean platelet volume, and soluble/platelet P-selectin as indexes of platelet function in atrial fibrillation: a comparison of "healthy control subjects" and "disease control subjects" in sinus rhythm J Am Coll Cardiol 49 2007 1957 1964